← Back to Blog
Italy ranks in the WHO global top 10 with 50+ IRCCS research hospitals publishing in The Lancet. Costs 30-60% lower than the UK or Germany — same clinical quality, faster access.
If you are exploring where to seek specialist treatment abroad, Italy is probably not the first country that springs to mind. Switzerland, perhaps. And yet, patients who dig deeper often pick the Bel Paese — not as a compromise, but as the safest and most advantageous choice for their medical health.
What many people don't realize is that Italy's strength comes from a unique structure you rarely encounter: the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS). These are not just hospitals — they're places where patient care and research are deeply intertwined. Recognized by the Italian Ministry of Health, they must continuously prove both their scientific contribution and the quality of their clinical outcomes to maintain this status. There are more than 50 across the country, and several are considered among the world's leading centers for cancer, cardiac, and neurological care.
Hospitals such as Ospedale San Raffaele, Istituto Europeo di Oncologia, and Fondazione Policlinico Universitario Agostino Gemelli are not only treating patients — they are actively shaping global medicine, with research published in journals like The Lancet, the New England Journal of Medicine, and leading PubMed-indexed studies. What is particularly striking is that the same physicians involved in these cutting-edge trials are often the ones who see private patients directly and with very limited waiting times.
What makes the IRCCS system so fascinating for international patients is the way it brings two worlds together within a single center. On one side, you have the discipline and depth of publicly funded medical research; on the other, highly streamlined, private, and international care pathways designed for faster access and greater comfort. At Ospedale San Raffaele, for instance, the same consultant leading a Phase III oncology trial may also see private international patients — often within just a few days from their first enquiry through the International Patient Unit. It is not a question of choosing between academic excellence and timely access; the system is structured so that you have access to both at once.
This combination is also what sets Italy aside in a broader European context, as highlighted in analyses of its research hospital model. Its excellency has been showcased, for example, in The Lancet's commentary on European academic health systems and in the comparative healthcare research indexed on PubMed.
Equally important is the cost structure, which reflects how the system has evolved. Unlike countries where healthcare is heavily market-driven, Italy's model is anchored in publicly funded research and hospitals built over decades rather than financed through high levels of debt or insurance pricing pressure. Surgeons and specialists are exceptionally skilled and world-renowned, yet not operating within the same compensation frameworks seen in the United States. The result is a system where, in many cases, overall treatment costs are 30 – 60% lower than in the UK or Germany, without any meaningful compromise in clinical quality or outcomes.
To put this into perspective:
| Procedure | Italy (private) | UK | USA |
|---|---|---|---|
| Hip or knee replacement | €8,000 – €13,000 | £18,000 – £25,000 | $40,000+ |
| Robotic-assisted oncology surgery | €15,000 – €25,000 | €40,000 – €60,000 | $60,000 – $100,000 |
| IVF cycle | €3,500 – €6,000 | £8,000 – £12,000 | $15,000 – $25,000 |
| Full dental implants | €12,000 – €18,000 | £25,000 – £35,000 | $40,000+ |
Oncological treatments such as chemotherapy protocols or robotic-assisted surgery follow a similar pattern — procedures that might cost €15,000 – €25,000 in Italy are routinely priced at two to three times that figure in equivalent German or Swiss centres. Even for more complex interventions such as cardiac surgery or spinal procedures, patients consistently report total costs — including pre-operative diagnostics, the procedure itself, and post-operative care — that remain significantly below what they would face at home.
Italy is, quietly, one of the most reachable countries in the world — something that often surprises people who assume it is harder to reach than Germany or France. In reality, it is exceptionally well connected. Milan Malpensa Airport and Rome Fiumicino Airport are among Europe's major long-distance hubs, with direct links to over 200 cities worldwide. For many of our international patients — particularly those travelling from the U.S., which represents one of our largest patient groups — the journey to Italy is often shorter and more advantageous than expected.
| Origin City | Destination | Flight Time | Airlines (direct) |
|---|---|---|---|
| London Heathrow | Milan MXP / Rome FCO | ~2h 20m | British Airways, ITA, EasyJet |
| Dubai (DXB) | Milan MXP / Rome FCO | ~6h 30m | Emirates, ITA Airways |
| Riyadh (RUH) | Rome FCO | ~5h 40m | Saudia, ITA Airways |
| Moscow (SVO) | Milan MXP | ~3h 30m | Aeroflot, ITA Airways |
| New York (JFK) | Rome FCO / Milan MXP | ~8h 30m | Delta, ITA, United |
| Beijing (PEK) | Rome FCO | ~11h | Air China, ITA Airways |
| Toronto (YYZ) | Rome FCO | ~9h | Air Canada, ITA Airways |
Once in Italy, travel within the country is just as straightforward. The high-speed rail system — Frecciarossa and Italo — connects Milan and Rome in under three hours. This is not just convenient; it makes a difference when planning care across the country. It is entirely realistic, for example, to obtain an oncological opinion in Milan and attend a follow-up consultation in Rome within the same trip, without logistical strain.
For non-EU patients requiring a medical visa, the process is also often simpler than expected. Most partner hospitals provide full supporting documentation, and international patient coordinators routinely assist with applications. In addition, the Schengen visa allows travel across 26 European countries, which is particularly valuable for patients who wish to bring family members and combine treatment with periods of rest or travel elsewhere in Europe.
In the end, what stands out about Italian medical excellence is not a single hospital or a single achievement, but the way the whole system works harmoniously and efficiently. It is a balance between world-class research, highly specialized doctors, and a public healthcare foundation that still keeps care widely accessible.
For patients, this often translates into something unexpectedly reassuring: clarity. Instead of navigating a fragmented or overly commercial system, you find yourself in an environment where leading clinicians, research hospitals, and international care teams are already working in connection with one another. Over time, this combination changes the way people experience healthcare. It shifts the focus away from uncertainty and towards trust — trust in the process, in the doctors, and in the outcomes.
Because of all this, Italy is now regarded as a primary healthcare hub, a first-class choice rather than a plan B. While the country is small and may not have the loudest voice in global healthcare, once you become closely acquainted with it becomes easy to trust its seriousness and professionalism.
For any enquiries or to discuss your specific case with a specialist, don't hesitate to reach out at [italycare360.com](https://italycare360.com).
We've answered thousands of enquiries on healthcare. These are the questions that come up most often — the ones that reflect what patients are genuinely uncertain about when they start this process.
Is Italian healthcare really world-class, or is that a marketing claim?
It's not a marketing claim — it's a peer-reviewed claim. Italy ranks in the global top 10 in the WHO World Health Report and hosts over 50 IRCCS nationally designated research hospitals. Institutions like IEO, San Raffaele, and Humanitas publish in The Lancet and The New England Journal of Medicine and are cited as reference centers by European clinical bodies. The quality is externally validated, not self-declared. You can check any hospital's publication record on PubMed.
How much can I realistically save — and what's the catch?
Savings typically run 30 – 60% depending on the procedure. Hip replacement: €8,000 – €14,000 in Italy vs £18,000 – £30,000 UK private. IVF: €3,500 – €6,000 vs £8,000 – £12,000. Full dental implants: €12,000 – €18,000 vs £25,000 – £35,000 London. The catch is real but manageable: you'll add travel and accommodation costs, and you'll need to plan for follow-up care at home. Our total trip cost calculator helps you model the full picture including flights and hotels. For most procedures, even with travel, the saving is substantial.
Will I actually be able to communicate? Do the doctors really speak English?
At every hospital in our directory, yes — fluently. The major IRCCS hospitals all have International Patient Units with English-speaking coordinators who manage everything from initial contact through discharge. Most senior consultants at these institutions have trained or published internationally in English; many did fellowships in the US or UK. Arabic, Russian, French, and German interpretation is also available. We won't list a hospital where we have any uncertainty about this.
If you are considering specialist treatment in Italy — whether for a planned procedure, a second opinion, or ongoing chronic care — our team can help you identify the right IRCCS hospital and consultant for your situation, in your language, with transparent timelines and costs.
Book a free 30-minute consultation with ITALYCARE 360. We'll review your case confidentially and provide a written summary with concrete next steps. No obligation.